Literature DB >> 18316599

MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.

Lynne T Bemis1, Robert Chen, Carol M Amato, Elizabeth H Classen, Steven E Robinson, David G Coffey, Paul F Erickson, Yiqun G Shellman, William A Robinson.   

Abstract

Micropthalmia-associated transcription factor (MITF) is the master regulator of melanocyte development, survival, and function. Frequent alteration in the expression of MITF is detected in melanoma, but the mechanism(s) underlying the alteration in expression have not been completely determined. In these studies, we have identified microRNA-137 (miR-137) as a regulator of MITF expression. The genomic locus of miR-137 at chromosome 1p22 places it in a region of the human genome previously determined to harbor an allele for melanoma susceptibility. Here, we show that expression of mature miR-137 in melanoma cell lines down-regulates MITF expression. Further, we have identified a 15-bp variable nucleotide tandem repeat located just 5' to the pre-miR-137 sequence, which alters the processing and function of miR-137 in melanoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316599     DOI: 10.1158/0008-5472.CAN-07-2912

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  105 in total

Review 1.  Genetic architectures of psychiatric disorders: the emerging picture and its implications.

Authors:  Patrick F Sullivan; Mark J Daly; Michael O'Donovan
Journal:  Nat Rev Genet       Date:  2012-07-10       Impact factor: 53.242

Review 2.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

3.  Melanoma MicroRNA signature predicts post-recurrence survival.

Authors:  Miguel F Segura; Ilana Belitskaya-Lévy; Amy E Rose; Jan Zakrzewski; Avital Gaziel; Douglas Hanniford; Farbod Darvishian; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Iman Osman; Eva Hernando
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

4.  MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.

Authors:  Bin Chen; Wenyan Pan; Xiaoxi Lin; Zhenzhen Hu; Yunbo Jin; Hui Chen; Gang Ma; Yajing Qiu; Lei Chang; Chen Hua; Yun Zou; Yang Gao; Hanru Ying; Dongze Lv
Journal:  Tumour Biol       Date:  2015-09-26

Review 5.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

Review 6.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

7.  MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.

Authors:  Sheng Liu; Juan Cui; Guoqing Liao; Yi Zhang; Ke Ye; Tailiang Lu; Jing Qi; Guohui Wan
Journal:  Tumour Biol       Date:  2014-06-12

8.  Differential regulation of schizophrenia-associated microRNA gene function by variable number tandem repeats (VNTR) polymorphism.

Authors:  Mohammed Mamdani; Gowon O McMichael; Venkat Gadepalli; Vernell Williamson; Erin K Parker; Vahram Haroutunian; Vladimir I Vladimirov
Journal:  Schizophr Res       Date:  2013-11-07       Impact factor: 4.939

Review 9.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

10.  Coat color determination by miR-137 mediated down-regulation of microphthalmia-associated transcription factor in a mouse model.

Authors:  Changsheng Dong; Haidong Wang; Linli Xue; Yanjun Dong; Lei Yang; Ruiwen Fan; Xiuju Yu; Xue Tian; Shuhui Ma; George W Smith
Journal:  RNA       Date:  2012-07-30       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.